The myo-inositol effect on the oocyte quality and fertilization rate among women with polycystic ovary syndrome undergoing assisted reproductive technology cycles: a randomized clinical trial
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Purpose The aim of the present study was to evaluate the effect of myo-Inositol administration on oocyte quality, fertilization rate and embryo quality in patients with PCOS during assisted reproductive technology (ART) cycles.Methods Fifty infertile PCOS patients were randomly designated in two groups. In the study group, patients received daily doses of 4 g myo-Inositol combined with 400 mg folic acid and in the control group patients received only 400 mg folic acid from 1 month before starting the antagonist cycle until the day of ovum pick up. Oocyte and embryo qualities were assessed according to European Society of Human Reproduction and Embryology (ESHRE) guidelines. The gene expression of PGK1, RGS2 and CDC42 as a factor of oocyte quality in granulosa cells was analyzed using real-time RT-PCR. Levels of total antioxidant capacity (TAC) and reactive oxygen species (ROS) were evaluated by chemiluminescence assay in follicular fluid.Results The percentage of metaphase II oocyte, fertilization rate and embryo quality significantly improved in the study group (p < 0.05), but the number of retrieved oocytes and follicle count were not statistically different between groups. Furthermore, the gene expression of PGK1, RGS2 and CDC42 was significantly higher in the study group (p < 0.05) but no differences were found between two groups in terms of TAC and ROS levels.Conclusions The present study findings suggest that myo-Inositol alters the gene expression in granulosa cells and improves oocyte and embryo quality among PCOS patients undergoing ART.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Twenty studies compared MI alone at doses of 1 to 4 g daily either alone or in combination with FA 200 to 400 mcg daily (25-27, 30-34, 41, 42, 44, 46-55) against the comparators of metformin, FA alone, or placebo.”
From Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines (2024) · cites this paper as [25]
In the citing paper
“Ten studies specifically enrolled women with PCOS who also had infertility (25, 27, 40, 46-51, 55, 56).”
From Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines (2024) · cites this paper as [25]
In the citing paper
“Ten used FA at doses ranging from 200 to 400 mcg daily (25, 27, 29, 31, 34, 37, 46-49).”
From Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines (2024) · cites this paper as [25]
In the citing paper
“There were 8 studies (25, 27, 31, 34, 46-49) that compared MI + FA to FA alone.”
From Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines (2024) · cites this paper as [25]
In the citing paper
“The dose of MI used was 4 g daily in 6 of the studies (25, 31, 46-49) with 200 to 400 mcg of FA.”
From Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines (2024) · cites this paper as [25]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
2 retracted
Papaleo, E., Unfer, V., Baillargeon, J.-P., Fusi, F., Occhi, F., & De Santis, L. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.01.088 · Cited by 197
RetractedPacchiarotti, A., Carlomagno, G., Antonini, G., & Pacchiarotti, A. (2016) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1101444 · Cited by 111
Retracted(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Men at risk: occupation and male infertility
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,387
Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., & the International PCOS Network (2018) · Clinical Endocrinology · doi:10.1111/cen.13795 · Cited by 1,823
Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., International PCOS Network, Andersen, M., et al. (2018) · Human Reproduction · doi:10.1093/humrep/dey256 · Cited by 1,593
Potential role and therapeutic interests of myo-inositol in metabolic diseases
Croze, M. L., & Soulage, C. O. (2013) · Biochimie · doi:10.1016/j.biochi.2013.05.011 · Cited by 578
Nelson, V. L., Legro, R. S., Strauss, J. F., & McAllister, J. M. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.6.0311 · Cited by 556
Cumulus and granulosa cell markers of oocyte and embryo quality
Uyar, A., Torrealday, S., & Seli, E. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.01.129 · Cited by 308
Metabolic control of oocyte development: linking maternal nutrition and reproductive outcomes
Gu, L., Liu, H., Gu, X., Boots, C., Moley, K. H., & Wang, Q. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1739-4 · Cited by 204
Research works printed but not linked: 1
- Benner A (1999) Sample size tables for clinical studies. (2nd edn). In: David Machin, Michael JC, Peter MF, Alain PY, Pinol, Blackwell Science Ltd., Oxford, 1997. No. of pages: x+315. Price: £45. ISBN 0-86542-870-0. Stat Med 18(4):494–495
Cited by
Mechanisms of oocyte aneuploidy associated with advanced maternal age
Mikwar, M., MacFarlane, A. J., & Marchetti, F. (2020) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2020.108320 · Cited by 308
Merviel, P., James, P., Bouée, S., Guillou, M. L., Rince, C., Nachtergaele, C., & Kerlan, V. (2021) · Reproductive Health · doi:10.1186/s12978-021-01073-3 · Cited by 120
Fitz, V., Graca, S., Mahalingaiah, S., Liu, J., Lai, L., Butt, A., Armour, M., Rao, V., Naidoo, D., Maunder, A., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad762 · Cited by 70
“One study did not clearly define treatment duration (48), and 1 study only provided inositol during IVF stimulation (47).”
BackgroundMethodInfluentialUnfer, V., Kandaraki, E., Pkhaladze, L., Roseff, S., Vazquez-Levin, M. H., Laganà, A. S., Chan, S. Y., Yap‐Garcia, M. I. M., Greene, N. D. E., Soulage, C. O., et al. (2024) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2024.100159 · Cited by 70
Melatonin and Myo-Inositol: Supporting Reproduction from the Oocyte to Birth
Russo, M., Forte, G., Oliva, M. M., Laganà, A. S., & Unfer, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168433 · Cited by 51
Myo-inositol in assisted reproductive technology from bench to bedside
Etrusco, A., Laganà, A. S., Chiàntera, V., Buzzaccarini, G., & Unfer, V. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.09.005 · Cited by 48
Female infertility in the era of obesity: The clash of two pandemics or inevitable consequence?
Medenica, S., Spoltore, M. E., Ormazabal, P., Marina, L., Šojat, A. S., Faggiano, A., Gnessi, L., Mazzilli, R., & Watanabe, M. (2022) · Clinical Endocrinology · doi:10.1111/cen.14785 · Cited by 32
Tabatabaie, M., Amiri, S., Jahromi, M. G., Sene, A. A., Zandieh, Z., Mehdizadeh, M., & Amjadi, F. (2022) · Molecular Biology Reports · doi:10.1007/s11033-021-06833-9 · Cited by 25
Self-citationKatyal, G., Kaur, G., Ashraf, H., Bodapati, A., Hanif, A., Okafor, D. K., & Khan, S. (2024) · Daehan saengsik uihak hoeji/Clinical and experimental reproductive medicine · doi:10.5653/cerm.2023.06485 · Cited by 24
Myo-Inositol and Its Derivatives: Their Roles in the Challenges of Infertility
Placidi, M., Casoli, G., Tatone, C., Emidio, G. D., & Bevilacqua, A. (2024) · Biology · doi:10.3390/biology13110936 · Cited by 20
Zhang, J., Zhang, H., Zhou, W., Jiang, M., & Lin, X.-H. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1520362 · Cited by 20
Tian, Y.-Q., Li, X., Wang, W.-J., Hao, H., Zou, H., Pang, Y., Zhao, X., Zhu, H., & Du, W. (2022) · Theriogenology · doi:10.1016/j.theriogenology.2022.05.015 · Cited by 19
Abdel-Maboud, M., Menshawy, A., Hasabo, E. A., Abdelraoof, M. I., Alshandidy, M., Eid, M., Menshawy, E., Outani, O., & Menshawy, A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0254412 · Cited by 18
RetractedAdvances in the study of CDC42 in the female reproductive system
Mei, Q., Li, H., Liu, Y., Wang, X., & Xiang, W. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17088 · Cited by 18
Sabz, F. T. K., Amjadi, F., Zandieh, Z., Hosseini, E., Aflatoonian, R., Tabatabaei, M., Mohammadian, M., & Ashrafi, M. (2022) · Andrologia · doi:10.1111/and.14427 · Cited by 15
Self-citationMasoudi, M., Yamini, N., Salehi, F., Aflatoonian, R., Azizi, M., Esfandiyari, S., Hosseini, E., Asadi, E., Najarkolaei, A. H., Mortezaee, K., et al. (2021) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-021-06039-1 · Cited by 14
Effects of myo-inositol plus folic acid on ovarian morphology and oocyte quality in PCOS mouse model
Haghighi, M., Mehdizadeh, M., Amjadi, F., Zandieh, Z., Najafi, M., Artimani, T., Mohammadi, F., & Mehdizadeh, R. (2023) · Zygote · doi:10.1017/s0967199422000557 · Cited by 13
Self-citationNovielli, C., Anelli, G. M., Lisso, F., Marzorati, A., Parrilla, B., Oneta, M., Savasi, V. M., Cetin, I., & Mandò, C. (2020) · Reproductive Biology · doi:10.1016/j.repbio.2020.10.002 · Cited by 12
Sene, A. A., Saeedzarandi, M., Yazdizadeh, M., Ghaffari, S. R., Amjadi, F., Zandieh, Z., & Moradi, Y. (2025) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.18502/ijrm.v23i5.19260 · Cited by 10
Self-citationPivazyan, L. G., Krylova, E., Obosyan, L. B., Seregina, V., Shapovalenko, R., & Ayryan, E. (2024) · Gynecologic and Obstetric Investigation · doi:10.1159/000540023 · Cited by 8
Yazdanpanah, Z., Cheraghi, E., Nasrabadi, M. H., & Salehipour, M. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03745-w · Cited by 9
The role of myo-inositol supplement in assisted reproductive techniques
Bashiri, Z., Sheibak, N., Amjadi, F., & Zandieh, Z. (2022) · Human Fertility · doi:10.1080/14647273.2022.2073273 · Cited by 8
Self-citationFares, K. S., Tayeh, G. A., Whaibeh, E. R., Louis, R. J., Jaalouk, L. Y., Matar, Y. M., & Nakhlé, M. M. (2025) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.18502/ijrm.v23i1.18188 · Cited by 6
Myo-inositol in the treatment of male factor infertility
Ших, Е. В., Grebenshikova, L. Y., Zhukova, О. V., & Bagdasaryan, A. A. (2022) · GYNECOLOGY · doi:10.26442/20795696.2022.4.201822 · Cited by 6
Sigue, R. J. L., & Decena, D. C. D. (2022) · Journal of Medicine University of Santo Tomas · doi:10.35460/2546-1621.2021-0141 · Cited by 6
Bejarano, I., Dorado-Silva, M., Sarmiento‐Soto, H., Álvarez‐Sánchez, N., Lardone, P. J., Guerrero, J. M., Sánchez-Martín, P., & Carrillo‐Vico, A. (2022) · Biology · doi:10.3390/biology11091361 · Cited by 5
Efficacy and safety of nutritional supplements in female infertility: a network meta-analysis
Du, J., Liu, J., Liu, Q., Li, C., Zhu, H., Ji, R., Shang, Z., Zheng, X., & Yang, J. (2025) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-025-01466-0 · Cited by 4
Yazdanpanah, Z., Nasrabadi, M. H., Cheraghi, E., & Salehipour, M. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-03952-z · Cited by 4
Palomba, S., Seminara, G., & Aversa, A. (2025) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2025.105269 · Cited by 3
Belchin, P., Calvente, V., Roso, M. J. G., Exposito, E. M. G., Bueno, A. S., Fluge, M. A., & Pérez, D. O. (2026) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2026.2681759 · Cited by 2
Factors Associated with In-Vitro Fertilization Success in Polycystic Ovary Syndrome
Hafezi, S. G., Pourganji, M., Ghamsary, M. G., Aghadavod, F., Habibian, F., Mozaffari, M. M., Metanat, S., & Eftekhar, M. (2024) · Journal of Obstetrics Gynecology and Cancer Research · doi:10.30699/jogcr.9.6.642 · Cited by 2
Bontá, S., Maggi, S., Rodríguez, R., Jiménez, R., Villaquirán, A. M., Pla, E., Fuentes, R., Luque, M. D., Ferrer, J., & Quintero, L. (2025) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-025-03763-4 · Cited by 2
Titova, M. S., Kolodina, M. I., Сергеевна, Л. А., & Lyashenko, E. N. (2022) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2022-16-16-50-56 · Cited by 2
FIRAT, S., & Fisunoğlu, M. (2021) · Akdeniz Medical Journal · doi:10.53394/akd.958775 · Cited by 1
Target therapy of polycystic ovary syndrome
Turchinets, A. I., Uvarova, E. V., Khashchenko, K. E. P., & Kumykova, Z. K. (2023) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2023-060 · Cited by 1
Kaya, C. (2026) · Journal of Health Sciences and Medicine · doi:10.32322/jhsm.1803630 · Cited by 1
Effect of Myo-Inositol Supplementation in Polycystic Ovary Syndrome—Scoping Review
Habryka, J., Ławniczek, M., & Krupa, S. (2026) · Nutrients · doi:10.3390/nu18132093 · Cited by 1
The Major Factors Affecting Oocyte Quality in IVF Cycles: A Narrative Review
Boueri, M. G., Saliba, M., Haydamous, J., Vargas, M. P. A., Hamam, M., Ashkar, R. A., Moujally, S. N., Maqbool, S., Bab, H. E., Mourad, A., et al. (2023) · International Journal of Clinical Research · doi:10.38179/ijcr.v3i1.277 · Cited by 1
Kratka, C. E., Grover, A. R., Pea, J., & Duncan, F. E. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21477-6.00377-1 · Cited by 1
Elfarjani, J., Choueiry, P., & Surveal, L. (2024) · Japan Journal of Research · doi:10.33425/2690-8077.1104
Khmil, S. V., & Калник, А. А. (2024) · Актуальні питання педіатрії акушерства та гінекології · doi:10.11603/24116-4944.2024.1.14741
Parker, P. B., Murphy, M. J., Ravisankar, S., Chavez, S. L., & Hennebold, J. D. (2025) · F&S Science · doi:10.1016/j.xfss.2025.02.007
Inositol supplementation in the management of Polycystic Ovary Syndrome
Zapalska, B. A., Witkowska, A. T., Żak-Gontarz, A., Minda, A., Janikowska, J., Piotrowska, J., Kowalska, A. Ł., Domańska, A., Witkowska, A., Wendland, M., et al. (2025) · Medical Science · doi:10.54905/disssi.v29i160.e82ms3608
Ганцгорн, Е. В., Максимов, М. Л., Kechkina, V. D., Rashkova, E. V., Колесникова, Н. А., & Безбородова, Е. Д. (2025) · Фармакология & Фармакотерапия · doi:10.46393/27132129_2025_4_32-38
Follicular fluid composition in the infertile women with polycystic ovary syndrome
Albergaria, I. D. C. (2021) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/xk5w-sz58
Mejías Jordan, P. (2025) · RIULL (Universidad de La Laguna)
Davoudi-Monfared, E., KIAIE, S. M. F., & Ebrahimi, M. (2026) · Journal of Family & Reproductive Health · doi:10.18502/jfrh.v20i1.22015
Garzon, S., Casprini, C., Mantovani, M., Porcari, I., Zorzato, P. C., Bosco, M., Laterza, R. M., Paladini, D., & Uccella, S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms272210101
Metadata
- Authors
- Akbari Sene, A., Tabatabaie, A., Nikniaz, H., Alizadeh, A., Sheibani, K., Mortezapour Alisaraie, M., Tabatabaie, M., Ashrafi, M., & Amjadi, F.
- Affiliations
- Iran University of Medical Sciences (IR)
- Royan Institute (IR)
- Basir Eye Health Research Center (IR)
- Corresponding author
- Amjadi, Fatemehsadat
- Venue
- Archives of Gynecology and Obstetrics
- Published
- 2019-03-27
- Volume
- 299
- Issue
- 6
- Pages
- 1701-1707
- ISSN
- 0003-9128 (ISSN-L)
- 0932-0067
- 1432-0711
- OpenAlex
- W2925323220
- Cited by
- 42
- References
- 44
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 7 · 2023: 5 · 2022: 9 · 2021: 6 · 2020: 2
- FWCI
- 4.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Archives of Gynecology and Obstetrics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Iran University of Medical Sciences (26493)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Keywords
- myo-inositol, polycystic ovary syndrome, oocyte quality, fertilization rate, embryo quality, granulosa cells, PGK1, RGS2, Cdc42, follicular fluid, reactive oxygen species, antioxidant capacity, folic acid, assisted reproduction, GnRH antagonist protocol
- MeSH terms
- Adult, Double-Blind Method, Female, Fertilization in Vitro, Folic Acid, Humans, Infertility, Female, Inositol, Oocytes, Polycystic Ovary Syndrome, Reproductive Techniques, Assisted
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.